ROTOP and IRE ELiT Form Distribution Partnership for the Ga-68 Generator GalliAd in Germany
Dresden (Germany), Fleurus (Belgium) – January 7, 2021 – ROTOP Pharmaka and IRE ELiT announce that they have entered into an exclusive distribution agreement for GalliAd, the 68Ge/68Ga generator from IRE ELiT, in Germany.
This strategic move represents an important step toward ensuring nationwide access to GalliAd generators in Germany. Existing GalliAd customers will continue to receive full support from ROTOP Pharmaka and will be informed about the details in the coming days.
Jens Junker, Managing Director of ROTOP Pharmaka, looks to the future with optimism: “We are proud to enter into a partnership with IRE ELiT, one of Europe’s leading radiopharmaceutical companies, driving innovation for the benefit of patients and nuclear medicine. With the GalliAd generator, ROTOP expands its radiopharmaceutical portfolio in Germany and continues its strategy of offering a broad range of radiopharmaceutical products.”
“This partnership will strengthen our position in the European market and contribute to the global development of this important radiopharmaceutical,” says Erich Kollegger, CEO of IRE ELiT. “Combining our expertise with ROTOP’s distribution strength will benefit both patients and nuclear medicine specialists.”
Ähnliche Beiträge
Symbolic Groundbreaking for ROTOP’s New CMO Center in Dresden-Rossendorf
September 21, 2026 - ROTOP today joined employees, project partners, representatives of the planning and construction companies involved, and guests from government and industry for a symbolic groundbreaking ceremony marking the upcoming start of construction on its new CMO Center in Dresden-Rossendorf. Guests included Dirk Hilbert, Mayor of Dresden, and Regina Kraushaar, Saxony's State Minister for Infrastructure and Regional Development.
Saxon State Parliament member Thomas Schmidt visits ROTOP
August 7, 2026 - A reunion with a long-standing companion: Saxon State Parliament member Thomas Schmidt visited our Radiopharmacy to learn about its development since its inauguration in 2020. The discussions focused on the future of radiopharmacy and nuclear medicine as well as the European framework for innovative diagnostic and therapeutic approaches.
ROTOP Receives Building Permit for New Radiopharmaceutical Manufacturing Facility in Dresden
April 27, 2026 - ROTOP Pharmaka GmbH today announced that it has received the building permit for a new radiopharmaceutical manufacturing facility in Dresden. The approval represents a major step in the company’s growth strategy and further strengthens its position as a leading radiopharmaceutical partner in Europe.
